News for Healthier Living

Children's Hospital Los Angeles Studies New Gene-Editing Approach for Sickle Cell Disease

Children's Hospital Los Angeles is participating in RESTORE, an early-stage clinical trial studying an investigational CRISPR-Cas9 therapy designed to directly modify the beta-globin gene in sickle cell disease.

July 27, 2026


July 28 2026

July 27 2026

July 26 2026

July 25 2026

July 24 2026

July 23 2026

July 22 2026

July 21 2026

July 20 2026

July 17 2026

July 16 2026

July 15 2026

July 14 2026